Skip to content
healthcare.dev
Get a free key

olopatadine hydrochloride

NDC 45802-104, Olopatadine Hydrochloride, spray, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-104
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
SPRAY
Route
NASAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202853
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-104 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLOPATADINE HYDROCHLORIDE665 ug/1

Pharmacologic classes

Decreased Histamine Release [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Mast Cell Stabilizer [EPC]

Package NDCNDC-11Package
45802-104-01458020104011 BOTTLE in 1 CARTON (45802-104-01) / 240 SPRAY in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/126ff6eb-62ae-46f2-ab1e-7ac19346c36b

  • NADAC price for package 45802010401

    GET /v1/drugs/nadac/45802010401

Use it

Look up 45802-104 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-104 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-104. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.